1,029
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Short-term administration of a small thyroxine dose to euthyroid type 2 diabetic patients improves the fasting lipoprotein profileFootnote#

, , , , , , & show all
Pages 1-6 | Received 12 Nov 2016, Accepted 29 Nov 2016, Published online: 09 Jan 2017

References

  • Snipelisky D, Ziajka P. Diabetes and hyperlipidemia: a direct quantitative analysis – a direct analysis of the effects of insulin resistance on lipid levels in relation to atherosclerotic coronary artery disease. World J Cardiovasc Dis. 2012;02:20–25.10.4236/wjcd.2012.21004
  • Balasubramanyam A. Diabetic dyslipidaemia. Medscape. 2001. Available from: http://www.medscape.org/viewarticle/418584
  • Spratt KA. Managing diabetic dyslipidemia: aggressive approach. J Am Osteopath Assoc. 2009;109(suppl 5):S2–S7.
  • Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab. 2006;91:4930–4937.10.1210/jc.2006-0478
  • Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J Clin Endocrinol Metab. 2008;93:2413–2415.10.1210/jc.2007-2832
  • Pucci E, Chiovato L, Pinchera A. Thyroid and lipid metabolism. Int J Obesity. 2000;24:S109–S112.10.1038/sj.ijo.0801292
  • Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76–84.10.2174/1874192401105010076
  • Wang F, Tan Y, Wang C, et al. Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones. J Clin Endocrinol Metab. 2012;97:2724–2731.10.1210/jc.2012-1133
  • Abbas JM, Chakraborty J, Akanji AO, et al. Hypothyroidism results in small dense LDL independent of IRS traits and hypertriglyceridemia. Endocr J. 2008;55:381–389.10.1507/endocrj.K07E-065
  • Hadlow NC, Rothacker KM, Wardrop R, et al. The relationship between TSH and free T4 in a large population is complex and nonlinear and differs by age and sex. J Clin Endocrinol Metab. 2013;98:2936–2943.10.1210/jc.2012-4223
  • Roos A, Bakker SJ, Links TP, et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92:491–496.10.1210/jc.2006-1718
  • Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010;163:273–278.10.1530/EJE-10-0312
  • van Tienhoven-Wind LJ, Dullaart RP. Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. Eur J Clin Invest. 2015;45:494–503.
  • van Tienhoven-Wind LJ, Dullaart RP. Low-normal thyroid function and novel cardiometabolic biomarkers. Nutrients. 2015;7:1352–1377.
  • Triolo M, Kwakernaak AJ, Perton FG, et al. Low normal thyroid function enhances plasma cholesteryl ester transfer in type 2 diabetes mellitus. Atherosclerosis. 2013;228:466–471.10.1016/j.atherosclerosis.2013.03.009
  • Lambadiari V, Mitrou P, Maratou, E, et al. Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes. Endocrine. 2011;39:28–32.10.1007/s12020-010-9408-3
  • Strollo F, Carucci I, Morè MG, et al. Free triiodothyronine and cholesterol levels in euthyroid elderly T2DM patients. Int J Endocrinol. 2012;2012:420370.
  • Zhang Y, Lu P, Zhang L, et al. Association between lipids profile and thyroid parameters in euthyroid diabetic subjects: a cross-sectional study. BMC Endocr Disord. 2015;15:151.10.1186/s12902-015-0008-3
  • Maratou E, Hadjidakis DJ, Peppa M, et al. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol. 2010;163:625–630.10.1530/EJE-10-0246
  • Lambadiari V, Spanoudi F, Maratou E, et al. Short term, low dose thyroxin treatment of euthyroid patients with type 2 diabetes improves peripheral blood flow and overall insulin sensitivity. J Diabetes Metab. 2016;7:677.
  • Pearce EN. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiol Rep. 2004;6:451–456.10.1007/s11886-004-0054-3
  • Santi A, Duarte MM, de Menezes CC, et al. Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism. Int J Endocrinol. 2012;2012:856359.
  • Lioudaki E, Mavroeidi NG, Mikhailidis DP, et al. Subclinical hypothyroidism and vascular risk: an update. Hormones. 2013;12:495–506.10.14310/horm.2002.1149
  • Kung AW, Pang RW, Lauder I, et al. Changes in serum lipoprotein (a) and lipids during treatment of hyperthyroidism. Clin Chem. 1995;41:226–231.
  • van Tienhoven-Wind LJ, Dullaart RP. Low normal thyroid function as a determinant of increased large very low density lipoprotein particles. Clin Biochem. 2015;48:489–494.
  • van Tienhoven-Wind LJ, Dallinga-Thie GM, Dullaart RP. Higher plasma ApoE levels are associated with low-normal thyroid function: studies in diabetic and non diabetic subjects. Horm Metab Res. 2016;48:462–467.
  • Zhang Y, Kim BK, Chang Y, et al. Thyroid hormones and coronary artery calcification in euthyroid men and women. Arterioscler Thromb Vasc Biol. 2014;34:2128–2134.10.1161/ATVBAHA.114.303889
  • Dullaart RP, de Vries R, Roozendaal C, et al. Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects. Clin Endocrinol. 2007;67:668–673.10.1111/cen.2007.67.issue-5
  • Takamura N, Akilzhanova A, Hayashida N, et al. Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. Atherosclerosis. 2009;204(2):e77–e81.10.1016/j.atherosclerosis.2008.09.022
  • Deetman PE, Kwakernaak AJ, Bakker SJ, et al. Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus. Thyroid. 2013;23:1367–1373.10.1089/thy.2013.0156
  • Bakker O, Hudig F, Meijssen S, et al. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun. 1998;249:517–521.10.1006/bbrc.1998.9174
  • Shin D, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J Biol Chem. 2003;278:1–5.
  • Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12:287–293.10.1089/10507250252949405
  • Triolo M, de Boer JF, Annema W, et al. Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemia. Clin Endocrinol. 2013;79:416–423.10.1111/cen.2013.79.issue-3
  • Taylor AH, Raymond J, Dionne JM, et al. Glucocorticoid increases rat apolipoprotein AI promoter activity. J Lipid Res. 1996;37:2232–2243.
  • Taylor AH, Wishart P, Lawless DE, et al. Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter. Biochemistry. 1996;35:8281–8288.10.1021/bi960269o
  • Blangero J, Blangero SW, Mahaney MC, et al. Effects of a major gene for apolipoprotein A-I concentration are thyroid hormone dependent in Mexican Americans. Arterioscler Thromb Vasc Biol. 1996;16:1177–1183.10.1161/01.ATV.16.9.1177
  • Davidson NO, Carlos RC, Drewek MJ, et al. Apolipoprotein gene expression in the rat is regulated in a tissue-specific manner by thyroid hormone. J Lipid Res. 1988;29:1511–1522.
  • Apostolopoulos JJ, Marshall JF, Howlett GJ. Triiodothryonine increases rat apolipoprotein A-I synthesis and alters high-density lipoprotein composition in vivo. Eur J Biochem. 1990;194:147–154.10.1111/ejb.1990.194.issue-1
  • Strobl W, Gorder NL, Lin-Lee Y, et al. Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver. J Clin Invest. 1990;85:659–667.10.1172/JCI114489
  • Romney JS, Chan J, Carr FE, et al. Identification of the thyroid hormone responsive messenger RNA spot 11 as apolipoprotein-A1 messenger RNA and effects of the hormone on the promoter. Mol Endocrinol. 1992;6:943–950.
  • Dimitriadis G, Boutati E, Lambadiari V, et al. Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism. Eur J Clin Invest. 2004;34:490–497.10.1111/eci.2004.34.issue-7